Guowei Fang
Chief Tech/Sci/R&D Officer bij LEGEND BIOTECH CORPORATION
Actieve functies van Guowei Fang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LEGEND BIOTECH CORPORATION | Chief Tech/Sci/R&D Officer | 01-03-2022 | - |
Loopbaan van Guowei Fang
Eerdere bekende functies van Guowei Fang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - | - |
Opleiding van Guowei Fang
| Nanjing University | Undergraduate Degree |
| University of Colorado Boulder | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Canada | 2 |
| China | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Beurs
- Insiders
- Guowei Fang
- Ervaring
